Company Filing History:
2 out of 2 
1 out of 65 
1 out of 10 Years Active: 2015-2020
Title: The Innovative Contributions of Thomas Hemetsberger
Introduction
Thomas Hemetsberger, an inventor based in Klosterneuburg, Austria, has made significant strides in the field of biomedicine with a focus on antibodies and therapeutic applications. With a total of four patents to his name, Hemetsberger's work has the potential to impact cancer treatment profoundly.
Latest Patents
Hemetsberger's most recent patents showcase his expertise and innovative spirit. One notable invention is a recombinant human IgM-antibody that is effective against cancer cells. This innovation includes a monoclonal pentameric IgM antibody that has the ability to bind to specific ganglioside epitopes, namely GD3, GM3, GD2, and GM1. Additionally, this antibody shows specific binding to malignant cancer cells, including melanoma, small cell lung cancer, glioblastoma, and estrogen receptor-negative metastatic breast cancer. The patent also covers a cell line capable of producing this IgM antibody, further emphasizing its therapeutic and diagnostic potential.
Another breakthrough is his method for enhancing the liquid formulation stability of erythropoietin alpha through purification processing. This multi-step filtration process not only provides a more stable rHuEPO product but also extends its shelf-life, marking a significant advancement in the production of this important therapeutic agent.
Career Highlights
Hemetsberger has accumulated valuable experience during his tenure at reputable companies such as Katinger GmbH and Apotex Inc. His work at these organizations has provided him with a platform to further his innovations and apply his expertise in real-world applications.
Collaborations
Throughout his career, Thomas Hemetsberger has collaborated with esteemed professionals, including Hermann W. Katinger and Renate Kunert. These partnerships have likely fueled the development of his inventive ideas, enabling him to leverage a network of knowledge and expertise in the biomedical field.
Conclusion
In summary, Thomas Hemetsberger stands out as a remarkable inventor whose work is shaping the future of cancer therapies and biomedicine. With a commendable number of patents and collaborations with notable professionals, Hemetsberger is positioning himself as a key player in the innovation landscape. His contributions promise not only to advance scientific understanding but also to enhance the lives of many battling cancer.